Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... .8 g/m vs 102.5±3.4 g/m² in Group 2 (p<0.05). The relative left ventricular wall thickness in Group 1 ..."
 
Vol 12, No 2 (2016) RESISTANT HYPERTENSION: THE AWARENESS OF DOCTORS AND THE EFFECTIVENESS OF THE COMBINATION THERAPY Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov, A. A. Pukhaeva
"... Aim. To study the doctor awareness of the criteria of resistant hypertension (RHT) and to evaluate ..."
 
Vol 11, No 6 (2015) Nephrogenic factors of resistance to antihypertensive treatment in patients with essential hypertension Abstract  similar documents
N. V. Teplova, V. A. Lyusov, R. G. Oganov, E. M. Evsikov, R. A. Sharipov, M. H. Zhapoeva, E. G. Kurumlidu
"... was performed. Results. A group of patients with resistant HT made 36.7% of the total number of examined ..."
 
Vol 17, No 2 (2021) Treatment of Resistant Hypertension in Real Clinical Settings Abstract  similar documents
A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin
"... with resistant hypertension, however, in real clinical settings the number of non-rational and ineffective ..."
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... characteristics of blood and platelets were found in the groups of ASA-resistant and ASA-sensitive patients 10 ..."
 
Vol 20, No 4 (2024) Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension Abstract  similar documents
O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova
"... , including diuretic. Patients with resistant hypertension are included in a group of people at high risk ..."
 
Vol 11, No 3 (2015) RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova
"... and vegetative status in patients with resistant hypertension (HT). Material and methods. Patients ..."
 
Vol 9, No 3 (2013) RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova, I. E. Deneka
"... A new method of non-drug treatment of resistant hypertension – renal denervation is considered ..."
 
Vol 11, No 2 (2015) RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE? Abstract  similar documents
Yu. I. Grinshtein, V. V. Shabalin
"... Resistant hypertension is defined as hypertension uncontrolled with optimal doses of three ..."
 
Vol 12, No 4 (2016) Resistant hypertension: epidemiology and risk factors Abstract  similar documents
I. E. Deneka, A. A. Svetankova, A. V. Rodionov
"... modifiable causes of resistant hypertension, that are often underestimated, are considered: obesity ..."
 
Vol 15, No 4 (2019) Resistant Hypertension: Questions and Contemporary Answers Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy
"... The review presents the important problem of resistant hypertension. Its real prevalence ..."
 
Vol 12, No 6 (2016) RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME Abstract  similar documents
O. M. Drapkina, J. S. Sibgatullina
"... Clinical case of resistant hypertension in a patient with metabolic syndrome is presented ..."
 
Vol 19, No 4 (2023) Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy Abstract  similar documents
S. R. Gilyarevsky, D. O. Ladygina
"... (MRAs), in particular spironolactone, in the treatment of hyperaldosteronism and resistant hypertension ..."
 
Vol 20, No 3 (2024) Theory and practice of selective imidazoline receptor agonist use in Russia Abstract  similar documents
N. I. Gaponova, V. R. Abdrakhmanov
 
Vol 16, No 1 (2020) Deprescribing Antihypertensive Drugs in Patients of Older Age Groups Abstract  similar documents
O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev
"... guidelines for the treatment of AH determine specific approaches for managing patients of older age groups ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... placebo (5.6±2.1 and 4.3±1.4, respectively , vs 8.6±2.4 episodes per month; p<0.05), the need ..."
 
Vol 6, No 6 (2010) WORKING GROUP OF THE YOUNG CARDIOLOGISTS HAS BEEN ESTABLISHED AT THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION Abstract  similar documents
"... Working group of the Young Cardiologists has been established at the Society of Cardiology ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..."
 
Vol 12, No 3 (2016) ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS Abstract  PDF (Eng)  similar documents
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov
"... with ischemic heart disease (IHD) in different age groups. Material and methods. Patients (n=678) with IHD aged ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
 
Vol 10, No 1 (2014) ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Schwartz
"... with adherence to treatment for chronic cardiovascular diseases in the group focused interview of patients ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... to group A (n=53) received clopidogrel 75 mg daily for 7 days before PCI, and later were allocated ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... groups with a history of myocardial infarction by the example of outpatient cardiology institution ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... patients were involved in the study and split into two groups. 100 patients (47 men, 53 women; aged 66,4±7 ..."
 
Vol 18, No 3 (2022) Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease Abstract  similar documents
K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein
"... P450 genes between the groups of aspirin-sensitive and aspirin-resistant patients, as well ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... groups. The patients were randomized into two groups: the group 1 (n=53) started treatment ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... into randomized, an open-label comparative stepped trial. The patients were randomized into two groups: the group ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... , in treatment of such conditions as primary hyperaldosteronism, resistant hypertension, edematous syndrome ..."
 
Vol 6, No 2 (2010) REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT Abstract  similar documents
A. N. Britov, M. M. Bystrova
"... Резистентную артериальную гипертонию (АГ) диагностируют, если при приеме трех антигипертензивных ..."
 
Vol 12, No 5 (2016) Arterial Hypertension in Patients with Rheumatoid Arthritis. What should be known and considered at diagnosis and treatment? Abstract  similar documents
N. M. Nikitina, T. A. Romanova, I. A. Afanas'ev, M. A. Tyapkina, A. P. Rebrov
"... patients with RA 7.5% of patients had resistant HT, 36.8% - do not regularly control BP. During daily ..."
 
Vol 14, No 6 (2018) Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 Abstract  PDF (Eng)  similar documents
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova
"... <0.05 in comparison with the group 1B). In the case of salt-resistant patients, there were comparable ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... ,6% among ASA sensitive patients and 50% - among ASA resistant patients. Repeated atherothrombotic events ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... aggregation after 7 days of the therapy compared to the basal levels (р<0,05). The highest incidence ..."
 
Vol 19, No 5 (2023) White coat effect in patients with hypertension Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova
"... , a large number of methods are used, which can be divided into following groups: I – data from clinical ..."
 
Vol 15, No 4 (2019) Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital Abstract  similar documents
O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova
"... in patients of the older age group of the therapeutic hospital, as well as combinations with other structural ..."
 
Vol 17, No 2 (2021) Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease Abstract  similar documents
T. Yu. Demidova, O. A. Kislyak
"... is that patients with DM and CKD represent a special group of patients with a very high risk of CVD ..."
 
Vol 15, No 4 (2019) Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis Abstract  PDF (Eng)  similar documents
E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova
"... of new groups of antibacterial drugs. This review includes the results of studies of the efficacy ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... . Despite progress in treatment of this disease, a number of people with uncontrolled or resistant HT ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... . Despite progress in treatment of this disease, a number of people with uncontrolled or resistant HT ..."
 
Vol 9, No 1 (2013) ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM Abstract  similar documents
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok
"... .7% (p<0.05), with reduced activity — on 33.3%, reduced motivation — on 25%. In group2 a number ..."
 
Vol 18, No 3 (2022) Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER Abstract  similar documents
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk
"... frequent use of angiotensin II receptor blockers in group 2, p<0.05), lipid profile and blood pressure ..."
 
Vol 18, No 5 (2022) Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age Abstract  similar documents
N. I. Solomakhina, A. S. Lishuta, A. V. Dementieva
"... with the ferrokinetic parameter – serum iron [r(S)=0.480, p<0.05] were found in the control group. Normal levels ..."
 
Vol 11, No 5 (2015) Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation Abstract  similar documents
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
"... (n=19; 57.6%) compared with the group TCZ+MTX (n=7; 18%), (p<0.05). The lipid levels correlated ..."
 
Vol 17, No 1 (2021) Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease Abstract  similar documents
M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush
"... group consisted of 30 healthy donors. The antiplatelet therapy was stopped for at least 5 days before ..."
 
Vol 8, No 4 (2012) THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova
"... — by 61.8%, after 2 months — 72.5%, p<0.05) were found in the intervention group compared with the control ..."
 
Vol 18, No 3 (2022) Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease Abstract  similar documents
A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov
"... ,543, respectively, p<0,05), and the level of Tyr with LDL (r=0,349, p<0,05). When isolating the group with proven ..."
 
Vol 6, No 4 (2010) MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION Abstract  similar documents
Z. M. Sizova, E. V. Shikh, V. L. Zakharova, E. V. Smirnova
"... in 2 groups. Patients of the 1st group (n=15) received nicorandil 20 mg TID, patients of the 2nd group ..."
 
Vol 8, No 1 (2012) THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova
"... , respectively (p>0.05). Target BP was achieved in 23 patients (77%) in both randomized groups. Serious adverse ..."
 
Vol 11, No 5 (2015) Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders Abstract  similar documents
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov
"... aneurysm 12% more often in patients of group 1 (p<0.05). The duration of inpatient treatment was also ..."
 
Vol 14, No 3 (2018) RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev
"... ×107) was lower than this in the control group (1.65±0.03×107; p<0.05). With MS duration more than 5 ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... and HCT was made more often in M group than in C group (p>0,05). Prescription of BB resulted ..."
 
Vol 14, No 2 (2018) CHANGE IN THE FUNCTIONAL STATE OF ERYTHROCYTES AS A COMPONENT OF MICROCIRCULATORY DISORDERS IN METABOLIC SYNDROME Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev
"... with MS was 7.3Ѓ}1.9%. The mean EEC level in group of MS patients (1.59Ѓ}0.05×107) was significantly lower ..."
 
Vol 7, No 5 (2011) ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS Abstract  similar documents
G. P. Arutyunov, L. G. Oganezova
"... ) in the urapidil group reduced from 210.5±13.6 to 157.8±8.3 mmHg (p<0.05), and diastolic BP (DBP) - from 115.7±8 ..."
 
Vol 17, No 1 (2021) Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease Abstract  similar documents
O. A. Fomina, S. S. Yakushin
"... into two groups: 103 patients (group 1; MINOCA) did not have obstructive involvement coronary arterial (CA ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... elective cardioversion was 21±2 and 30.5±4.5 days for dabigatran and warfarin groups, respectively (p<0.05 ..."
 
Vol 8, No 3 (2012) COMPARATIVE EFFECTIVENESS PIPOFEZINE, TIANEPTINE AND CHLORPROTHIXENE IN PATIENTS WITH ATTENTION DEFICIT DISORDER , AND HYPERTENSION: AN OPEN NON-RANDOMIZED STUDY Abstract  similar documents
V. V. Glushchenko
"... of neurophysiological parameters (increase in EEG frequencies index) in groups 1 and 2 (from 0.37±0.05 to 0.54±0 ..."
 
Vol 18, No 4 (2022) Refractory Arterial Hypertension: Features of Neurohormonal and Water-salt Imbalanceand Approaches to Antihypertensive Drug Therapy Abstract  similar documents
O. B. Kuzmin, V. V. Zhezha
"... from patients with resistant hypertension with the higher of sympathetic nervous system activity ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... increased by 18.2% (p<0.05). Group 2: the average CHF class decreased by 29.6% (p<0.01), EF increased by 18 ..."
 
Vol 15, No 1 (2019) How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? Abstract  similar documents
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov
"... -vessel disease (15% vs 25.6%; p<0.05) between groups 3 and 4. Glomerular filtration rate (GFR) <60 ml/min ..."
 
Vol 8, No 5 (2012) POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov
"... of patients in the group 2 was significantly older than this in patients of the group 1 (p<0.05). CTI, left ..."
 
Vol 14, No 1 (2018) THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina
"... , as compared to the USA one, most age groups demonstrate a higher concentration of total cholesterol, i.e. p<0.05 ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... . Material and methods. The first group included 131 patients with PA who sought medical attention ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... ) scheduled for laparoscopic cholecystectomy were examined. Patients were randomized into 2 groups. Patients ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... .4 мs2, respectively. SDNN rose from 27.8±3.2 to 52.4±4.4 ms (p<0.05) in the second group, from 27.4±2 ..."
 
Vol 17, No 4 (2021) Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology Abstract  similar documents
O. N. Tkacheva, Yu. V. Kotovskaya, N. K. Runikhina, E. V. Frolova, V. S. Ostapenko, N. V. Sharashkina, E. I. Baranova, S. V. Bulgakova, S. V. Villevalde, D. V. Duplyakov, A. N. Ilnitskiy, O. A. Kislyak, Zh. D. Kobalava, A. O. Konradi, S. V. Nedogoda, Ya. A. Orlova, N. V. Pogosova, K. I. Proshchaev, G. A. Chumakova
"... in these groups of patients indicate an increase in morbidity and mortality with lower blood pressure ..."
 
Vol 7, No 6 (2011) MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS Abstract  similar documents
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya
"... .410). The frequency of stroke in patients with and without MAC did not differ (p>0.05). In the group of patients ..."
 
Vol 7, No 3 (2011) COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) Abstract  similar documents
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva
"... times - in women (p<0.05) in group A, and in 2.7 and 3.3 times, respectively , — in the control group (p ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients ..."
 
Vol 18, No 6 (2022) Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease Abstract  similar documents
N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov
"... volunteers (p <0.001). There were no significant differences between the main and control groups (p>0.05 ..."
 
Vol 18, No 5 (2022) Pararenalfat Tissue: Rate of Pararenal Obesity and Relation with Anthropometric Indices of Obesity Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy, J. N. Rodionova, D. A. Bayutina
"... was detected on a single slice at the level of the left renal vein. Results. 27% of the examined group had BMI ..."
 
Vol 17, No 2 (2021) Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care Abstract  PDF (Eng)  similar documents
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova
"... patients. These groups were comparable in terms of sex (female 71.2 vs 68.0%; p>0.05) and age (median 73 ..."
 
Vol 15, No 1 (2019) Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction Abstract  PDF (Eng)  similar documents
Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy
"... into 2 groups (group A received bolus I/C eptifibatide and group B received it I/V) followed by 12-hour ..."
 
Vol 9, No 1 (2013) ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION Abstract  similar documents
A. N. Zakirova, E. R. Abdukova, N. E. Zakirova
"... in the study. All participants were divided into four groups according to the presence of AF and CHF class ..."
 
Vol 8, No 2 (2012) QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL Abstract  similar documents
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
"... .0) points (p<0.05). At the same period opposite dynamics was observed in patients of the control group after ..."
 
Vol 17, No 4 (2021) E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina, L. N. Mohammadi
"... inhaled nicotine dose. In the group of vapers, CRP was associated with smoking experience (rs=0.338, p<0.05 ..."
 
Vol 18, No 5 (2022) The Role of Structured Telephone Support in the Development of Self-care in Comorbid Patients with Chronic Heart Failure Abstract  PDF (Eng)  similar documents
E. D. Kartamysheva, Yu. M. Lopatin
"... in the telephone support group (p>0.05).However, there were no statistically significant differences in the intake ..."
 
Vol 17, No 5 (2021) A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases Abstract  PDF (Eng)  similar documents
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva
"... in the intervention group continued taking statins versus 29 (43%) respondents in the control group (p<0.05), 3 months ..."
 
Vol 8, No 3 (2012) EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE Abstract  similar documents
T. N. Khaybullin, E. Yu. Kravtsova, G. A. Martynova
"... ) and 20 healthy subjects matched for age and sex (control group) were included in the study. IS patients ..."
 
Vol 18, No 1 (2022) Arterial Stiffness Parameters and Subendocardial Viability Ratio in Patients with Arterial Hypertension Affected by Subclinical and Clinical Atherosclerosis Abstract  similar documents
V. E. Gumerova, V. V. Gomonova, S. A. Sayganov
"... .3±1.8, 11.5±1.7 respectively; p<0.05) compared with control group (SBP 116.3±7.3; SBPao 108.9±6.4, PP ..."
 
Vol 7, No 2 (2011) A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina
"... .5±8.6 beats/min in group 2 (p<0.05 for both groups). Significant dynamics of PQ interval were ..."
 
Vol 18, No 6 (2022) The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation Abstract  similar documents
A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev
"... class III to II increased in the sacubitril/valsartan group (p<0.05). Also, in this group, the effective ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... % (p<0.001) in the main group. Decrease in total cholesterol (TC) by -3.6% (p<0.05) and increase ..."
 
Vol 18, No 2 (2022) Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction Abstract  similar documents
Zh. D. Kobalava, A. F. Safarova, Kh. M. Gudieva, M. A. Markova, A. E. Petrosyan
"... in the second group reached the target clinical BP (р<0,05). Average daily BP <130/ <80 mm Hg was reached by 82 ..."
 
Vol 18, No 3 (2022) The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Abstract  PDF (Eng)  similar documents
O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov
"... , patients were randomized into 2 groups: EECP (n=15) and a comparison group (n=15). All patients (n=30 ..."
 
Vol 2, No 2 (2006) COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
M. N. Mamedov, T. V. Ektova, O. A. Litinskaya, T. Sh. Dzhakhangirov, O. V. Kosmatova
"... in the 1st group increased by 14% before glucose load, and by 25% (p<0,05) 2 hours after peroral glucose ..."
 
Vol 16, No 3 (2020) Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina Abstract  similar documents
S. A. Boldueva, I. A. Leonova, O. V. Zakharova
"... into the study and randomized into 3 groups. Patients of the first group (control; n=30) received standard ..."
 
Vol 18, No 4 (2022) Left Atrium Involvement in Lymphoma Patients: Single Center Observational Study Abstract  similar documents
E. Yu. Salakheeva, I. Ya. Sokolova, O. V. Lyapidevskaya, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, V. O. Stebakova, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov, A. A. Shchendrygina
"... no prior polychemotherapy. The comparison group included persons without lymphoma [n=18; 50% men; median ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... by 17.1±5.8/11.4±4.0 mmHg (p<0.05) was revealed in the main group and by 13.6±4.7/8.9±5.3 mm Hg ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... was equally achieved in both treatment arms. The fasting glucose level increased in the atenolol group from 4 ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... patients that are resistant to clopidogrel (PRU>208) and in patients with a normal response to clopidogrel ..."
 
Vol 10, No 2 (2014) PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM Abstract  PDF (Eng)  similar documents
A. M. Kalinina, A. V. Kontsevaya
"... to the second group, fatal MI incidence rate was 42.4% lower, p<0.05. Mortality rate in new cases of MI was 35 ..."
 
Vol 11, No 2 (2015) DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES Abstract  similar documents
A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko
"... .53; p<0.05), while in the group with PEF, the correlation was not significant (p=0.225). In the group ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... of BNP was also found in Group 1 by 60% (p=0.005), and in Group 2 – by 33.8% (p<0.001). The levels of CPK ..."
 
Vol 18, No 2 (2022) The Influence of Multivessel Bypass Surgery on the Onset of Atrial Fibrillation in Elderly Patients Abstract  similar documents
O. A. Rubanenko, A. O. Rubanenko
"... . Patients were divided into 4 groups: 1 group – with single-vessel bypass, 2 group – with 2-vessels, 3 group ..."
 
Vol 4, No 4 (2008) EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY Abstract  similar documents
V. V. Jakusevich, N. V. Semenova, I. A. Tihomirova, A. V. Muravyov, S. V. Lychenko
"... randomized (3:1) on Memoplant (240 mg/daily) treatment group and control group. Duration of observation ..."
 
Vol 3, No 5 (2007) RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS Abstract  similar documents
I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova
"... not differ in control group. Positive correlation  r=0,61; p<0,05) between GGFR and a tobacco smoking ..."
 
Vol 13, No 1 (2017) CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION Abstract  similar documents
V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova
"... (–) group, in the RT(+) group after PCI VT were recorded more frequently (44% vs 63.6%, respectively; p<0.05 ..."
 
Vol 12, No 6 (2016) BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION Abstract  similar documents
Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova
"... }3.67 points vs 24.6Ѓ}4.3 and 20.1Ѓ}5.7 points in group 2, and group of healthy, respectively; p<0.05 ..."
 
Vol 3, No 2 (2007) CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) Abstract  similar documents
V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin
"... patients (3,4%) of group II (1993) and in 10 of 531 patients (1,9%) of group 3 (2003), (p1,3 <0,05 ..."
 
1 - 100 of 954 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)